1Figueiredo ML, Kim Y, St John MA, et al. P12 (CDK2-AP1) gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer [J]. Clin Cancer Res, 2005, 11 (10): 3939-3948.
2Shintani S, Mihara M, Terakado N, et al. Reduction of p 12D OC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma [J]. Clin Cancer Res, 2001, 7 (9): 2776-2782.
3Hiyoshi Y, Watanabe M, Hirashima K, et al. p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous ceil carcinoma [J]. Oncol Rep, 2009, 22(1): 35-39.
4Choi MG, Sohn TS, Park SB, et al. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues [J]. Eur Surg ges, 2009, 42(4): 223-229.
5Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system [J]. J Virol, 1998, 72(11): 8463- 8471.
6Gopinathan L, Ratnacaram CK, Kaldis P. Established and novel cdk/cyclin complexes regulating the cell cycle and development [J]. Results Probl Cell Differ, 2011, 53: 365-389.
7Zolochevska O, Figueiredo ML. Cell-cycle regulators CDK2- AP1 and bicalntamide suppress malignant biological interactions between prostate cancer and bone cells [J]. Prostate, 2011, 71(4): 353-367.
8Shintani S, Ohyama H, Zhang X, et al. p12(DOC-1) is a novel cyclin- dependent kinase 2-associated protein [J]. Mol Cell Biol, 2000, 20(17): 6300-6307.
9Todd R, McBride J, Tsuji T, et aL Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene [J]. FASEBJ, 1995, 9(13): 1362-1370.
10Tsuji , Duh FM, Latif F, et al. Cloning, mapping, expression, function,and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene doc-1 [J].J Biol Chem, 1998, 273(12): 6704- 6709.
